Overview

Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the bioequivalence of Mylan's fluoxetine hydrochloride 40 mg capsules to Dista's Prozac 40 mg pulvules following a single, oral 40 mg (1 x 40 mg) dose administration under fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Mylan Pharmaceuticals
Treatments:
Fluoxetine